Archives of Pediatric Infectious Diseases

Published by: Kowsar

Prevalence and Antibiotic Susceptibility of Shigella Species Isolated From Pediatric Patients in Tehran

Amir Talebreza 1 , Mojtaba Memariani 2 , * , Hamed Memariani 3 , Mohammad Hasan Shirazi 4 , Parvaneh Eghbali Shamsabad 5 and Maryam Bakhtiari 2
Authors Information
1 Department of Surgery, Faculty of Medicine, AJA University of Medical Sciences, Tehran, IR Iran
2 Shahid Fallahi Polyclinic, AJA University of Medical Sciences, Tehran, IR Iran
3 Biotechnology Research Center, Pasteur Institute of Iran, Tehran, IR Iran
4 Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
5 Department of Environmental Science, Graduate School of the Environment and Energy, Science and Research Branch, Islamic Azad University, Tehran, IR Iran
Article information
  • Archives of Pediatric Infectious Diseases: January 01, 2016, 4 (1); e32395
  • Published Online: December 27, 2015
  • Article Type: Research Article
  • Received: August 14, 2015
  • Revised: October 2, 2015
  • Accepted: November 1, 2015
  • DOI: 10.5812/pedinfect.32395

To Cite: Talebreza A, Memariani M, Memariani H, Shirazi M H, Eghbali Shamsabad P, et al. Prevalence and Antibiotic Susceptibility of Shigella Species Isolated From Pediatric Patients in Tehran, Arch Pediatr Infect Dis. 2016 ; 4(1):e32395. doi: 10.5812/pedinfect.32395.

Abstract
Copyright © 2015, Pediartric Infections Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, et al. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999; 77(8): 651-66[PubMed]
  • 2. Ranjbar R, Soltan-Dallal MM, Pourshafie MR, Mammina C. Antibiotic resistance among Shigella serogroups isolated in Tehran, Iran (2002-2004). J Infect Dev Ctries. 2009; 3(8): 647-8[PubMed]
  • 3. Ranjbar R, Ghazi FM, Farshad S, Giammanco GM, Aleo A, Owlia P, et al. The occurrence of extended-spectrum beta-lactamase producing Shigella spp. in Tehran, Iran. Iran J Microbiol. 2013; 5(2): 108-12[PubMed]
  • 4. Bakhshi B, Eftekhari N, Pourshafie MR. Genetic elements associated with antimicrobial resistance among intestinal bacteria. Jundishapur J Microbiol. 2014; 7(5)[DOI][PubMed]
  • 5. Ashkenazi S, Levy I, Kazaronovski V, Samra Z. Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother. 2003; 51(2): 427-9[PubMed]
  • 6. Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, Afsharpaiman S, et al. Frequency and antimicrobial susceptibility of Shigella species isolated in Children Medical Center Hospital, Tehran, Iran, 2001-2006. Braz J Infect Dis. 2010; 14(2): 153-7[PubMed]
  • 7. Zeighami H, Haghi F, Hajiahmadi F, Kashefiyeh M, Memariani M. Multi-drug-resistant enterotoxigenic and enterohemorrhagic Escherichia coli isolated from children with diarrhea. J Chemother. 2015; 27(3): 152-5[DOI][PubMed]
  • 8. Wikler M, Cockerill F, Craig W, Dudley M, Eliopoulos G, Hecht P, et al. Clinical and laboratory standards institute: Performance standards for antimicrobial disk susceptibility tests. 9 ed. USA: Clinical and Laboratory Standards Institute; 2006;
  • 9. Jomezadeh N, Babamoradi S, Kalantar E, Javaherizadeh H. Isolation and antibiotic susceptibility of Shigella species from stool samples among hospitalized children in Abadan, Iran. Gastroenterol Hepatol Bed Bench. 2014; 7(4): 218-23[PubMed]
  • 10. Savadkoohi RB, Ahmadpour-Kacho M. Prevalence of Shigella species and their antimicrobial resistance patterns at Amirkola children hospital, North of Iran. Iran J Pediatr. 2007; 17: 118-22
  • 11. Opintan J, Newman MJ. Distribution of serogroups and serotypes of multiple drug resistant Shigella isolates. Ghana Med J. 2007; 41(1): 8-29[PubMed]
  • 12. Njunda AL, Assob JC, Nsagha DS, Kamga HL, Awafong MP, Weledji EP. Epidemiological, clinical features and susceptibility pattern of shigellosis in the buea health district, Cameroon. BMC Res Notes. 2012; 5: 54[DOI][PubMed]
  • 13. Nath R, Saikia L, Choudhury G, Sharma D. Drug resistant Shigella flexneri in & around Dibrugarh, north-east India. Indian J Med Res. 2013; 137(1): 183-6[PubMed]
  • 14. MoezArdalan K, Zali MR, Dallal MM, Hemami MR, Salmanzadeh-Ahrabi S. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhoea in Karaj, Tehran, Iran. J Health Popul Nutr. 2003; 21(2): 96-102[PubMed]
  • 15. Shiferaw B, Solghan S, Palmer A, Joyce K, Barzilay EJ, Krueger A. Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010. Am Clinic infect dis. 2012; 54(5): 458-63
  • 16. Banga Singh KK, Ojha SC, Deris ZZ, Rahman RA. A 9-year study of shigellosis in Northeast Malaysia: Antimicrobial susceptibility and shifting species dominance. Z Gesundh Wiss. 2011; 19(3): 231-6[DOI][PubMed]
  • 17. Eftekhari N, Bakhshi B, Pourshafie MR, Zarbakhsh B, Rahbar M, Hajia M, et al. Genetic diversity of Shigella spp. and their integron content. Foodborne Pathog Dis. 2013; 10(3): 237-42[DOI][PubMed]
  • 18. Tajbakhsh M, Garcia Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, Zali MR, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012; 67(5): 1128-33[DOI][PubMed]
  • 19. Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A. Characterization of Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. J Clin Microbiol. 2006; 44(8): 2879-83[DOI][PubMed]
  • 20. Pazhani GP, Ramamurthy T, Mitra U, Bhattacharya SK, Niyogi SK. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol Infect. 2005; 133(6): 1089-95[DOI][PubMed]
  • 21. Fulla N, Prado V, Duran C, Lagos R, Levine MM. Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg. 2005; 72(6): 851-4[PubMed]
  • 22. Ansari S, Sherchand JB, Parajuli K, Mishra SK, Dahal RK, Shrestha S, et al. Bacterial etiology of acute diarrhea in children under five years of age. J Nepal Health Res Counc. 2012; 10(22): 218-23[PubMed]
  • 23. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the national antimicrobial resistance monitoring system from 1999 to 2002. Antimicrob Agents Chemother. 2006; 50(1): 49-54[DOI][PubMed]
  • 24. Wong MR, Reddy V, Hanson H, Johnson KM, Tsoi B, Cokes C, et al. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009. Microb Drug Resist. 2010; 16(2): 155-61[DOI][PubMed]
  • 25. Erdman SM, Buckner EE, Hindler JF. Options for treating resistant Shigella species infections in children. J Pediatr Pharmacol Ther. 2008; 13(1): 29-43[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments